simvastatin has been researched along with Barrett Epithelium in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, L; Fullerton, DA; Gergen, AK; Li, A; Madsen, HJ; Meng, X; Pratap, A; Weyant, MJ | 1 |
| Beer, DG; Chang, AC; Ferrer-Torres, D; Hinton, T; Jiang, H; Lagisetty, K; Lawrence, TS; Lin, J; Nancarrow, D; Owens, S; Ray, D; Ray, P; San Martinho, M; Thomas, D; Wang, Z; Yoon, HW | 1 |
| Duan, Z; El-Serag, HB; Kramer, JR; Naik, AD; Nguyen, T | 1 |
| Burnat, G; Hahn, EG; Konturek, PC | 1 |
| Beales, IL; Ogunwobi, OO | 1 |
| Hawk, ET; Viner, JL | 1 |
6 other study(ies) available for simvastatin and Barrett Epithelium
| Article | Year |
|---|---|
Simvastatin Inhibits Histologic Changes Associated with Gastroduodenal Reflux in a Murine Model.
Topics: Adenocarcinoma; Animals; Annexin A5; Barrett Esophagus; Caspase 3; Disease Models, Animal; Esophageal Neoplasms; Esophagitis, Peptic; Gastroesophageal Reflux; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Simvastatin | 2022 |
Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.
Topics: Adenocarcinoma; Animals; Barrett Esophagus; Cells, Cultured; Down-Regulation; Esophageal Neoplasms; Esophagus; Female; Gene Expression; Gene Silencing; Glycosylation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-gamma; Isoenzymes; Mice; Mice, Nude; Neoplasm Transplantation; RNA, Messenger; Signal Transduction; Simvastatin; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases | 2020 |
Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
Topics: Adenocarcinoma; Adult; Aged; Barrett Esophagus; Case-Control Studies; Chemoprevention; Dose-Response Relationship, Drug; Esophageal Neoplasms; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Logistic Models; Male; Middle Aged; Neoplasm Staging; Pharmacoepidemiology; Risk Assessment; Simvastatin; United States; Veterans | 2015 |
Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Barrett Esophagus; bcl-2-Associated X Protein; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Dose-Response Relationship, Drug; Esophageal Neoplasms; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin | 2007 |
Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Apoptosis; Barrett Esophagus; Caspase 3; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Esophageal Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Lovastatin; Mevalonic Acid; Nitrobenzenes; Polyisoprenyl Phosphates; Pravastatin; Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Signal Transduction; Simvastatin; Sulfonamides | 2008 |
Statins in esophageal cancer cell lines: promising lead?
Topics: Adenocarcinoma; Animals; Apoptosis; Barrett Esophagus; Cell Line, Tumor; Dose-Response Relationship, Drug; Esophageal Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Simvastatin | 2008 |